Summary Safety Review - PRADAXA (dabigatran etexilate) - Assessing the potential risk of liver injury
Données et ressources
Info additionnelle
| Champ | Valeur |
|---|---|
| Dernière modification | avril 17, 2026, 17:39 (TU) |
| Créé le | avril 17, 2026, 17:39 (TU) |
| criticality_level | [] |
| geographic_scope | [] |
| open_canada_collection | publication |
| open_canada_date_published | 2018-05-07 00:00:00 |
| open_canada_keywords | {"fr": ["Résumé de l'examen de l'innocuité", "PRADAXA", "dabigatran etexilate", "évaluation", "risque potentiel", "lésion hépatique"], "en": ["Summary Safety Review", "PRADAXA", "dabigatran etexilate", "assessing", "potential risk", "liver injury"]} |
| open_canada_subject | ["health_and_safety"] |
| sensitivity_level | unrestricted |
| title_fr | Résumé de l’examen de l’innocuité - PRADAXA (dabigatran étexilate) - Évaluation du risque potentiel de lésions du foie |
| update_frequency | as_needed |